date,title,source
Oct-19-18,"BeyondSpring to Host Second-Quarter 2018 Financial Results and Operational Update Conference Call on October 23, 2018",GlobeNewswire
Oct-23-18,"BeyondSprings Lead Asset, Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia, Has the Potential to Positively Impact Tumor Microenvironment",GlobeNewswire
Oct-23-18,Beyondspring Provides Operational Update and Second-Quarter 2018 Financial Results,GlobeNewswire
Oct-23-18,"BeyondSpring Announces Top Line Positive Efficacy and Safety Data from Phase 2 Study 106 with Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia Prevention",GlobeNewswire
Nov-21-18,"Research Report Identifies Chicken Soup for the Soul Entertainment, Allied Motion Technologies, Bandwidth, Solid Biosciences, Avenue Therapeutics, and BeyondSpring with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Nov-27-18,Plinabulin Newly Granted Patent Covering Method of Use in Prevention of Neutropenia,GlobeNewswire
Nov-30-18,Can The Uptrend Continue for BeyondSpring (BYSI)?,Zacks
Dec-04-18,"Data for BeyondSprings Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia (CIN) Prevention Shows Differentiated Profile Compared with G-CSF and Adds Additional Protection to G-CSF",GlobeNewswire
Dec-06-18,BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis,GlobeNewswire
Dec-21-18,United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSprings Lead Asset Plinabulin with Protection to 2036,GlobeNewswire
Dec-27-18,"BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin",GlobeNewswire
Jan-17-19,How to spot risky biotech companies and six to avoid now,MarketWatch
